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Background This study aims to compare stigma perception between
candidates to obesity surgery and patients who were already submitted to
surgical treatment.
Methods Two groups of patients were assessed:
– Group1: 57 patients already submitted to obesity surgery, with a mean
body mass index (BMI) of 36.20 (SD=7.34).
– Group 2: 34 patients, candidates to obesity surgery, with a mean BMI of
43.21 (SD=6.55).
There were no statistically significant differences between the two groups
concerning age, gender, school level, disease duration and civil status. Neverthe-
less, Group 1 patients’ present a lower body mass index than Group 2 patients’.
Patients answered to the Stigma Scalein the context a personal interview.
Results Data analysis revealed that there are no statistically significant
differences between the two groups of patients concerning stigma perception –
to feel different from other people, t(88)=1.66; p>.05; to feel that, because of his/
her condition, the others feel uneasy, t(88)=.76; p>.05; to feel the others avoid
him/her because of his/her condition, t(88)=1.56; p>.05; to feel that his/her
condition prejudices his/her relationship with friends, t(88)=.47; p>.05. The single
domain in which we have observed significant differences was to feel the others
are afraid of him/her because of his/her condition, t(88)=2.27; p>.05, perception
that is higher in Group 2 patients’. Stigma perception showed not to be high in
patients of both groups.
Conclusions Contrary to the common-sense idea, this study shows that
stigma perception associated to obesity is not high in candidates to obesity
surgery and in patients who were submitted to obesity surgical treatment.
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Background This study aims to compare well-being and ill-being (nervous
system, muscular, respiratory and digestive symptoms) between candidates to
obesity surgery and patients who were already submitted to surgical treatment.
Methods Two groups of patients were assessed:
– Group1: 57 patients already submitted to obesity surgery, with a mean
body mass index (BMI) of 36.20 (SD=7.34).
– Group 2: 34 patients, candidates to obesity surgery, with a mean BMI of
43.21 (SD=6.55).
There were no statistically significant differences between the two groups
concerning age, gender, school level, disease duration and civil status.
Nevertheless, Group 1 patients’ presented a lower body mass index than
Group 2 patients’. Patients answered to the General Well-Beingand to an Ill-
Being Scale in the context a personal interview.
Results Data analysis suggested that there are no statistically significant
differences between the two groups of patients concerning global ill-being, t
(89)=1.97; p>.05, nervous system symptoms, t(87)=1.47; p>.05, and
digestive symptoms, t(89)=.43; p>.05. Nevertheless, patients who were
already submitted to obesity surgical treatment report higher well-being, t(89)
=3.80; p>.05, and lower ill-being related to muscular, t(88)=2.12; p>.05, and
respiratory symptoms, t(89)=2.81; p>.05. Moreover, patients of both groups
revealed to present a medium level of well-being and of global ill-being
(namely of muscular symptoms), but high level of nervous system symptoms
and low level of respiratory and digestive symptoms.
Conclusions Surgical treatment seems to contribute to better well-being and
to the improvement of ill-being in patients suffering from obesity. Nevertheless
it will be necessary to develop longitudinal studies to confirm this impact.
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Background Obesity in an independent risk factor for bariatric surgery.
Previous studies have shown, that a preoperative weight loss is associated
with a better long term outcome, fewer complications, and less time in the
operation room in bariatric patients. However preoperative weight loss is hard
to achieve in many patients.
Methods We therefore conducted a study in which 25 bariatric patients
received 15 mg of the weight loss medication sibutramine prior to laparoscopic
roux-en-y gastric bypass. It was our interest to find out, if these patients had a
benefit compared to a control group who did not receive medication.
Result Obesity in an independent risk factor for bariatric surgery. Previous
studies have shown, that a preoperative weight loss is associated with a better
long term outcome, fewer complications, and less time in the operation room in
bariatric patients. However preoperative weight loss is hard to achieve in many
patients. We therefore conducted a study in which 25 bariatric patients received
15 mg of the weight loss medication sibutramine prior to laparoscopic roux-en-y
gastric bypass. It was our interest to find out, if these patients had a benefit
compared to a control group who did not receive medication.
Conclusion Medical therapy with sibutramine in preparation for bariatric
surgery can improve health status of patients and lead to a reduction of liver
size and operating time. It should be considered as an alternative or addition
to dietary therapy or gastric balloon treatment in preparation of patients
expecting a roux-en-y gastric bypass.
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Background The so-called “high-risk pregnancy” represents an emotional and
a social problem. The objective of this study was to identify the emotional
questions involved in the diagnosis of gestational Diabetes Mellitus, with
hospitalized pregnant women whose BMI was over 30.
Methods This was a retrospective study with 72 pregnant women, which
made use of a semi-structured interview protocol.
Results The average age was 27 years. As for the gestational age, 30% were
in their first quarter, 40%, in their second quarter, and 30%, in their third
OBES SURG (2009) 19:953–1076 1031
